fenofibric acid 135 MG Delayed Release Oral Capsule [Trilipix]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

fenofibric acid 135 MG Delayed Release Oral Capsule [Trilipix]

135 MG · Delayed Release Oral Capsule · oral

A form of fenofibric acid →

fenofibric acid 135 MG Delayed Release Oral Capsule [Trilipix] — Fibrates. Strength, form, class, interactions & more.

fenofibric acid 135 MG Delayed Release Oral Capsule [Trilipix]

Active ingredient

Classification

FibratesPeroxisome Proliferator-activated Receptor alpha Agonist

Drug interactions

Fenofibric acid has several drug interactions that may affect its efficacy and safety.

  • majorCoumarin Anticoagulants — Potentiation of coumarin-type anticoagulant effect with prolongation of PT/INR
  • moderateBile Acid Binding Resins — Impeded absorption of fenofibric acid
  • majorImmunosuppressants — Risk of nephrotoxicity and deterioration of renal function
  • majorColchicine — Risk of myopathy, including rhabdomyolysis

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.